97 related articles for article (PubMed ID: 29608744)
21. Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease : Effects of modern radiotherapy techniques.
Corradini S; Ballhausen H; Weingandt H; Freislederer P; Schönecker S; Niyazi M; Simonetto C; Eidemüller M; Ganswindt U; Belka C
Strahlenther Onkol; 2018 Mar; 194(3):196-205. PubMed ID: 28916844
[TBL] [Abstract][Full Text] [Related]
22. Triple-rule-out computed tomography angiography with 256-slice computed tomography scanners: patient-specific assessment of radiation burden and associated cancer risk.
Perisinakis K; Seimenis I; Tzedakis A; Papadakis AE; Damilakis J
Invest Radiol; 2012 Feb; 47(2):109-15. PubMed ID: 21857528
[TBL] [Abstract][Full Text] [Related]
23. Low dose radiation therapy for COVID-19: Effective dose and estimation of cancer risk.
García-Hernández T; Romero-Expósito M; Sánchez-Nieto B
Radiother Oncol; 2020 Dec; 153():289-295. PubMed ID: 33065184
[TBL] [Abstract][Full Text] [Related]
24. Screening computed tomography colonography with 256-slice scanning: should patient radiation burden and associated cancer risk constitute a major concern?
Perisinakis K; Seimenis I; Tzedakis A; Papadakis AE; Kourinou KM; Damilakis J
Invest Radiol; 2012 Aug; 47(8):451-6. PubMed ID: 22766908
[TBL] [Abstract][Full Text] [Related]
25. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
Vogel J; Lin L; Litzky LA; Berman AT; Simone CB
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):427-433. PubMed ID: 28871993
[TBL] [Abstract][Full Text] [Related]
26. A framework for estimating radiation-related cancer risks in Japan from the 2011 Fukushima nuclear accident.
Walsh L; Zhang W; Shore RE; Auvinen A; Laurier D; Wakeford R; Jacob P; Gent N; Anspaugh LR; Schüz J; Kesminiene A; van Deventer E; Tritscher A; del Rosarion Pérez M
Radiat Res; 2014 Nov; 182(5):556-72. PubMed ID: 25251702
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.
Travis LB; Hill DA; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Wiklund T; Lynch CF; Van't Veer MB; Glimelius I; Storm H; Pukkala E; Stovall M; Curtis R; Boice JD; Gilbert E
JAMA; 2003 Jul; 290(4):465-75. PubMed ID: 12876089
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy-induced secondary cancer risk for breast cancer: 3D conformal therapy versus IMRT versus VMAT.
Lee B; Lee S; Sung J; Yoon M
J Radiol Prot; 2014 Jun; 34(2):325-31. PubMed ID: 24705154
[TBL] [Abstract][Full Text] [Related]
29. The risk of second primary cancers due to peripheral photon and neutron doses received during prostate cancer external beam radiation therapy.
Bezak E; Takam R; Yeoh E; Marcu LG
Phys Med; 2017 Oct; 42():253-258. PubMed ID: 28302493
[TBL] [Abstract][Full Text] [Related]
30. Estimated risk for secondary cancer in the contra-lateral breast following radiation therapy of breast cancer.
Johansen S; Danielsen T; Olsen DR
Acta Oncol; 2008; 47(3):391-6. PubMed ID: 18348001
[TBL] [Abstract][Full Text] [Related]
31. Second malignancies in high‑dose areas of previous tumor radiotherapy.
Welte B; Suhr P; Bottke D; Bartkowiak D; Dörr W; Trott KR; Wiegel T
Strahlenther Onkol; 2010 Mar; 186(3):174-9. PubMed ID: 20339826
[TBL] [Abstract][Full Text] [Related]
32. Organ-specific radiation-induced cancer risk estimates due to radiotherapy for benign pigmented villonodular synovitis.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Phys Med Biol; 2016 Sep; 61(17):6400-12. PubMed ID: 27499236
[TBL] [Abstract][Full Text] [Related]
33. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.
Hodgson DC; Koh ES; Tran TH; Heydarian M; Tsang R; Pintilie M; Xu T; Huang L; Sachs RK; Brenner DJ
Cancer; 2007 Dec; 110(11):2576-86. PubMed ID: 17941006
[TBL] [Abstract][Full Text] [Related]
34. Special radiobiological features of second cancer risk after particle radiotherapy.
Trott KR
Phys Med; 2017 Oct; 42():221-227. PubMed ID: 29103987
[TBL] [Abstract][Full Text] [Related]
35. The influence of inter-fractional anatomy variation on secondary cancer risk estimates following radiotherapy.
Stokkevåg CH; Engeseth GM; Hysing LB; Ytre-Hauge KS; Muren LP
Phys Med; 2017 Oct; 42():271-276. PubMed ID: 28941739
[TBL] [Abstract][Full Text] [Related]
36. Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer.
Murray L; Mason J; Henry AM; Hoskin P; Siebert FA; Venselaar J; Bownes P;
Radiother Oncol; 2016 Aug; 120(2):293-9. PubMed ID: 27370205
[TBL] [Abstract][Full Text] [Related]
37. Cancer risk estimates from radiation therapy for heterotopic ossification prophylaxis after total hip arthroplasty.
Mazonakis M; Berris T; Lyraraki E; Damilakis J
Med Phys; 2013 Oct; 40(10):101702. PubMed ID: 24089892
[TBL] [Abstract][Full Text] [Related]
38. A critical evaluation of secondary cancer risk models applied to Monte Carlo dose distributions of 2-dimensional, 3-dimensional conformal and hybrid intensity-modulated radiation therapy for breast cancer.
Joosten A; Bochud F; Moeckli R
Phys Med Biol; 2014 Aug; 59(16):4697-722. PubMed ID: 25082795
[TBL] [Abstract][Full Text] [Related]
39. Risk of second primary lung cancer in women after radiotherapy for breast cancer.
Grantzau T; Thomsen MS; Væth M; Overgaard J
Radiother Oncol; 2014 Jun; 111(3):366-73. PubMed ID: 24909095
[TBL] [Abstract][Full Text] [Related]
40. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
